Skip to main content
SpringerLink
Log in

Management der axialen Spondyloarthritis

Management of axial spondyloarthritis

  • Schwerpunkt: Management rheumatischer Erkrankungen
  • Published:
Der Internist Aims and scope Submit manuscript

Zusammenfassung

Der Begriff Spondyloarthritiden (SpA) umfasst eine Gruppe von rheumatischen Erkrankungen, die neben einer Entzündung des Achsenskeletts (Sakroiliitis, Spondylitis) auch durch eine Entzündung peripherer Gelenke (Arthritis) und Sehnenansätze (Enthesitis) charakterisiert ist. Das Management der Erkrankung orientiert sich an der aktuellen Krankheitsmanifestation, der Krankheitsaktivität und der Einschränkung der Funktionsfähigkeit. Im vorliegenden Übersichtsbeitrag wird auf die Diagnose und Therapie der axialen SpA eingegangen. Die diagnostischen Prozeduren werden insbesondere vor dem Hintergrund der diagnostischen Wertigkeit und Praktikabilität in der klinischen Routine vorgestellt. Die Darstellung therapeutischer Optionen umfasst Bewegungsübungen wie auch medikamentöse Therapiemaßnahmen und invasive Prozeduren.

Abstract

The term spondyloarthritis (SpA) is now increasingly used to classify and diagnose patients who are characterized by inflammation in the axial skeleton and peripheral manifestations (arthritis and enthesitis). The management of SpA should be tailored according to the current manifestations of the disease, the disease activity and functional impairment. The current article focuses on diagnosis and therapy in patients with axial SpA. Diagnostic procedures are discussed in light of diagnostic utility and feasibility in daily routine care. Cornerstones of treatment in patients with axial SpA are a combination of regular exercise and pharmacological treatment options aiming at anti-inflammatory strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127–2137

    Article  PubMed  Google Scholar 

  2. Rudwaleit M et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): Validation and final selection. Ann Rheum Dis 68(6):777–783

    Article  CAS  PubMed  Google Scholar 

  3. Rudwaleit M et al (2011) The Assessment of SpondyloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis 70(1):25–31

    Article  CAS  PubMed  Google Scholar 

  4. Smith JA, Colbert RA (2014) The IL-23/IL-17 axis in spondyloarthritis pathogenesis: Th17 and beyond. Arthritis Rheum 66:231–241

    Article  CAS  Google Scholar 

  5. Neidhart M et al (2009) Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis. Ann Rheum Dis 68(8):1334–1339

    Article  CAS  PubMed  Google Scholar 

  6. Van der Heijde D et al (2016) 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis 75(Suppl 2):44

    Google Scholar 

  7. Kiltz U, Braun J (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew’s disease and early forms: Editorial. Z Rheumatol 73(Suppl 2):20–22

    Article  PubMed  Google Scholar 

  8. Rudwaleit M et al (2006) Inflammatory back pain in ankylosing spondylitis: A reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum 54(2):569–578

    Article  PubMed  Google Scholar 

  9. Essers I et al (2015) Characteristics associated with the presence and development of extra-articular manifestations in ankylosing spondylitis: 12-year results from OASIS. Rheumatology (Oxford) 54(4):633–640

    Article  Google Scholar 

  10. Feldtkeller E et al (2003) Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 23(2):61–66

    PubMed  Google Scholar 

  11. Ramiro S et al (2015) Reference intervals of spinal mobility measures in normal individuals: the MOBILITY study. Ann Rheum Dis 74(6):1218–1224

    Article  PubMed  Google Scholar 

  12. Sieper J et al (2009) The Assessment of SpondyloArthritis international Society (ASAS) handbook: A guide to assess spondyloarthritis. Ann Rheum Dis 68(Suppl 2):ii1–ii44

    Article  PubMed  Google Scholar 

  13. Poddubnyy D et al (2012) Baseline radiographic damage, elevated acute-phase reactant levels, and cigarette smoking status predict spinal radiographic progression in early axial spondylarthritis. Arthritis Rheum 64(5):1388–1398

    Article  PubMed  Google Scholar 

  14. Braun J et al (1998) Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 41(1):58–67

    Article  CAS  PubMed  Google Scholar 

  15. Kiltz U et al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew’s disease and early forms: 8.3 Nonpharmaceutical therapeutic measures. Z Rheumatol 73(Suppl 2):71–77

    Article  PubMed  Google Scholar 

  16. Kiltz U et al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew’s disease and early forms: 8.4 Pharmaceutical therapy, 8.5 Evaluation of therapy success of pharmaceutical measures. Z Rheumatol 73(Suppl 2):78–96

    Article  PubMed  Google Scholar 

  17. Rudwaleit M et al (2009) The early disease stage in axial spondylarthritis: Results from the German Spondyloarthritis Inception Cohort. Arthritis Rheum 60(3):717–727

    Article  CAS  PubMed  Google Scholar 

  18. Poddubnyy D et al (2012) Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis 71(10):1616–1622

    Article  CAS  PubMed  Google Scholar 

  19. Maxwell LJ et al (2015) TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev 4:CD005468

    Google Scholar 

  20. Baraliakos X et al (2013) Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis. Ann Rheum Dis 73(4):710–715. doi:10.1136/annrheumdis-2012-202698

    Article  PubMed  Google Scholar 

  21. Navarro-Compan V et al (2016) Anti-TNF discontinuation and tapering strategies in patients with axial spondyloarthritis: A systematic literature review. Rheumatology (Oxford) 55(7):1188–1194. doi:10.1093/rheumatology/kew033

    Article  Google Scholar 

  22. Baeten D et al (2015) Secukinumab, an Interleukin-17A inhibitor, in Ankylosing Spondylitis. N Engl J Med 373(26):2534–2548

    Article  CAS  PubMed  Google Scholar 

  23. Kiltz U et al (2014) German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew’s disease and early forms: 8.6 Invasive therapy. Z Rheumatol 73(Suppl 2):97–100

    Article  PubMed  Google Scholar 

  24. Heuft-Dorenbosch L et al (2007) Performance of various criteria sets in patients with inflammatory back pain of short duration; The Maastricht early spondyloarthritis clinic. Ann Rheum Dis 66(1):92–98

    Article  CAS  PubMed  Google Scholar 

  25. Wanders A et al (2005) Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum 52(6):1756–1765

    Article  CAS  PubMed  Google Scholar 

  26. Sieper J et al (2015) Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: Results from a randomised multicentre trial (ENRADAS). Ann Rheum Dis 75(8):1438–1443. doi:10.1136/annrheumdis-2015-207897

    Article  PubMed  Google Scholar 

  27. van der Heijde D et al (2008) Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 58(5):1324–1331

    Article  PubMed  Google Scholar 

  28. Rudwaleit M et al (2005) The challenge of diagnosis and classification in early ankylosing spondylitis. Do we need new criteria? Arthritis Rheum 52(4):1000–1008

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumazentrum Ruhrgebiet, Claudiusstr. 45, 44649, Herne, Deutschland

    U. Kiltz, X. Baraliakos & J. Braun

Authors
  1. U. Kiltz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Baraliakos
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Braun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to U. Kiltz.

Ethics declarations

Interessenkonflikt

U. Kiltz, X. Baraliakos und J. Braun geben an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.

Additional information

Redaktion

E. Märker-Hermann, Wiesbaden

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kiltz, U., Baraliakos, X. & Braun, J. Management der axialen Spondyloarthritis. Internist 57, 1060–1068 (2016). https://doi.org/10.1007/s00108-016-0140-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00108-016-0140-9

Schlüsselwörter

Keywords

Search

Navigation